2020 IDP Foundation Research Innovation Challenge Award Recipients Announced

The Lurie Cancer Center is pleased to announce the recipients of the 2020 IDP / Sherman Fairchild Foundation Research Innovation Challenge Awards. Funded by a generous donation from the IDP Foundation, including a generous supplementary donation from the Sherman Fairchild Foundation, these grants support innovative, team-driven cancer research projects that are translational in nature, and also cross-disciplinary and collaborative in design and conduct.

It is anticipated that these awards will support projects that could evolve to SPORE or PO1 applications and, in some cases, large multi-PI R01s.

The 2020 award recipients are:

		“Steroid receptor coactivators as potential targets for inhibition in prostate cancer” Co-Principal Investigators: Ishwar Radhakrishnan, PhD and Jindan Yu, MD, PhD
		“Development of a brain-penetrant GPX4 inhibitor to exploit ferroptosis vulnerabilty of IDH1-wt glioblastoma” Co-Principal Investigators : Alexander Stegh, PhD and Gary Schiltz, PhD